Skip to main content
Clinical Trials/NCT05476549
NCT05476549CompletedNot Applicable

Effects of Lemon Verbena Extract Supplementation on Behaviour Mood and Cognitive Function in Sub-ADHD Children

Northumbria University1 site in 1 country140 target enrollmentStarted: August 4, 2022Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
140
Locations
1
Primary Endpoint
Change in depression-dejection from baseline to 8 weeks

Study Overview

Brief Summary

The aim of this study is to investigate the effects of 15 mg/kg lemon verbena, in comparison to placebo, on the attention deficit hyperactivity disorder (ADHD) type behaviour and cognitive function of children who do not have a diagnosis of ADHD, but who exhibit high scores (highest tertile) on ADHD behaviour parameters. Multiple aspects of mood will also be assessed.

The proposed randomised, double-blind, placebo-controlled, parallel groups design methodology will assess the psychological effects of 15 mg/kg lemon verbena extract and a matched placebo prior to and after 4 and 8 weeks of supplementation. The trial will utilise the COMPASS cognitive assessment system (Northumbria University) and a range of mood measures during laboratory testing visits.

Parents and children will also take part in a concomitant smartphone study, comprising the collection of the parent's assessment of the child's behaviour/cognitive function and the child's self-report of the same, plus their mood. These assessments will take place on Days -1, 14, 28, 42 and 56.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Basic Science
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
8 Years to 17 Years (Child)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Are in good health as reported by themselves and their parent/guardian
  • •Are aged 8 to 17 years at the time of giving assent and parents giving consent
  • •Have a sex and age-related BMI less than the 98th centile according to the local NHS guidelines
  • •Are rated by their parents as having a high score (T score of ≥60) on both the Connors 3 subscales of Inattention and Hyperactivity/Impulsivity.
  • •Have no current diagnosis of ADHD
  • •Have no relevant food intolerances/ sensitivities/ allergies
  • •Are not currently using any illicit, herbal or recreational drugs including alcohol and nicotine products
  • •Are not currently taking prescription medications
  • •Have not taken dietary supplements e.g. Vitamins, omega 3 fish oils etc. in the last 4 weeks
  • •Do not have a diagnosed neurological condition, or learning/behavioural or neurodevelopmental differences (e.g. dyslexia, autism)
  • •Do not suffer from visual (including colour blindness) impairment that cannot be corrected with glasses or lenses (that may impact task performance in the opinion of the PI).
  • •Do not have any pre-existing diagnosed medical condition/illness which will impact taking part in the study
  • •Consume less than 250 mg/day of caffeine.
  • •Can complete all of the study assessments at the training visit
  • •Are not currently participating in other clinical or nutrition intervention studies, or have in the past 4 weeks
  • •Are compliant with regards to treatment consumption
  • •Have not taken antibiotics within the past 4 weeks
  • •Do not have any health condition that would prevent fulfilment of the study requirements (this includes non-diagnosed conditions for which no medication may be taken)

Exclusion Criteria

  • Not provided

Arms & Interventions

Lemon verbena

Experimental

Intervention: Lemon verbena (Dietary Supplement)

Placebo

Placebo Comparator

Intervention: Placebo (Dietary Supplement)

Outcomes

Primary Outcomes

Change in depression-dejection from baseline to 8 weeks

Time Frame: Baseline to 8 weeks

Profile of mood states questionnaire

Change in systolic blood pressure from baseline to 8 weeks

Time Frame: Baseline to 8 weeks

Systolic blood pressure (mmHg)

Change in diastolic blood pressure from baseline to 8 weeks

Time Frame: Baseline to 8 weeks

Diastolic blood pressure (mmHg)

Change in heart rate during the performance of cognitive tasks from baseline to 8 weeks

Time Frame: Baseline to 8 weeks

Beats per minute

Change in confusion-bewilderment from baseline to 8 weeks

Time Frame: Baseline to 8 weeks

Profile of mood states questionnaire

Change in body temperature from baseline to 8 weeks

Time Frame: Baseline to 8 weeks

Degrees Celsius

Change in RMSSD during the performance of cognitive tasks from baseline to 8 weeks

Time Frame: Baseline to 8 weeks

Root mean square of successive differences between normal heartbeats (RMSSD)

Change in Conners 3 score from baseline to 8 weeks, parent rating

Time Frame: Baseline to 8 weeks

Change in heart rate variability index during the performance of cognitive tasks from baseline to 8 weeks

Time Frame: Baseline to 8 weeks

Heart rate variability index

Change in subjective mood from baseline to 8 weeks, alertness

Time Frame: Baseline to 8 weeks

Visual analogue scale composite score

Change in Conners 3 score from baseline to 8 weeks, child rating

Time Frame: Baseline to 8 weeks

Change in anger-hostility from baseline to 8 weeks

Time Frame: Baseline to 8 weeks

Profile of mood states questionnaire

Change in subjective perceived stress from baseline to 8 weeks

Time Frame: Baseline to 8 weeks

Perceived stress scale (PSS) total score

Change in reaction time of performance on arrow flankers task from baseline to 8 weeks

Time Frame: Baseline to 8 weeks

Cognitive task score, reaction time in milliseconds

Change in reaction time of performance on rapid visual information processing task from baseline to 8 weeks

Time Frame: Baseline to 8 weeks

Cognitive task score, reaction time in milliseconds

Change in total mood disturbance from baseline to 8 weeks

Time Frame: Baseline to 8 weeks

Profile of mood states questionnaire

Change in tension-anxiety from baseline to 8 weeks

Time Frame: Baseline to 8 weeks

Profile of mood states questionnaire

Change in vigour-activity from baseline to 8 weeks

Time Frame: Baseline to 8 weeks

Profile of mood states questionnaire

Change in fatigue-inertia from baseline to 8 weeks

Time Frame: Baseline to 8 weeks

Profile of mood states questionnaire

Change in stress index during the performance of cognitive tasks from baseline to 8 weeks

Time Frame: Baseline to 8 weeks

The stress index is a measure of the ratio between the parasympathetic and sympathetic tone. intervals exceeds 50 milliseconds.

Change in subjective mood from baseline to 8 weeks, stress

Time Frame: Baseline to 8 weeks

Visual analogue scale composite score

Change in accuracy of performance from baseline to 8 weeks

Time Frame: Baseline to 8 weeks

Cognitive task composite score, %

Change in accuracy of performance on arrow flankers task from baseline to 8 weeks

Time Frame: Baseline to 8 weeks

Cognitive task score, %

Change in accuracy of performance on Corsi blocks task from baseline to 8 weeks

Time Frame: Baseline to 8 weeks

Cognitive task score, %

Change in accuracy of performance on rapid visual information processing task from baseline to 8 weeks

Time Frame: Baseline to 8 weeks

Cognitive task score, %

Change in reaction time of performance on Stroop task from baseline to 8 weeks

Time Frame: Baseline to 8 weeks

Cognitive task score, reaction time in milliseconds

Change in pNN50 during the performance of cognitive tasks from baseline to 8 weeks

Time Frame: Baseline to 8 weeks

pNN50 is the mean number of times per hour in which the change in consecutive normal sinus (NN) intervals exceeds 50 milliseconds.

Change in subjective anxiety from baseline to 8 weeks

Time Frame: Baseline to 8 weeks

State-trait anxiety inventory (STAI) total score

Change in subjective mood from baseline to 8 weeks, tranquility

Time Frame: Baseline to 8 weeks

Visual analogue scale composite score

Change in accuracy of performance on Stroop task from baseline to 8 weeks

Time Frame: Baseline to 8 weeks

Cognitive task score, %

Change in reaction time of performance on numeric working memory task from baseline to 8 weeks

Time Frame: Baseline to 8 weeks

Cognitive task score, reaction time in milliseconds

Change in completion time of peg and ball task from baseline to 8 weeks

Time Frame: Baseline to 8 weeks

Cognitive task score, time in milliseconds

Change in speed of performance from baseline to 8 weeks

Time Frame: Baseline to 8 weeks

Cognitive task composite score, milliseconds

Change in accuracy of performance on numeric working memory task from baseline to 8 weeks

Time Frame: Baseline to 8 weeks

Cognitive task score, %

Change in accuracy of performance on peg and ball task from baseline to 8 weeks

Time Frame: Baseline to 8 weeks

Cognitive task score, number of errors

Change in false alarms on rapid visual information processing task from baseline to 8 weeks

Time Frame: Baseline to 8 weeks

Cognitive task score, number of false alarms

Change in thinking time of peg and ball task from baseline to 8 weeks

Time Frame: Baseline to 8 weeks

Cognitive task score, time in milliseconds

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials